You Searched For "eli lilly stock price" and got 20 results
Sort By:
2 mins read
Eli Lilly just halved the price of its weight-loss drug — declaring war on the booming market of knock-offs
Eli Lilly is now offering cheaper single-dose vials of its wildly popular weight-loss drug Zepbound…
Gabby Landsverk
1 min read
'Unbelievable demand' for weight-loss drugs sends Eli Lilly stock soaring 14% after earnings
"We just see unbelievable demand, and we're not even trying that hard to promote this drug. We're n…
Matthew Fox
3 mins read
Weight loss and diabetes drug Tirzepatide will cost Rs 80,000 per month in India
Tirzepatide is set to make its debut in the Indian market under the brand name Mounjaro for the tre…
1 min read
Eli Lilly is now worth more than Tesla as the EV maker's stock spirals
Eli Lilly's valuation closed at $595 billion on Thursday, more than Tesla's $581 billion, as the EV…
Aruni Soni
1 min read
Retail traders have been ditching the Magnificent 7 for pharma stocks like Eli Lilly, says JPMorgan
Nividia is still a retail darling, but last week saw individual investors pivot to names like Eli L…
Yuheng Zhan
2 mins read
Eli Lilly soars 8% after Q1 earnings reveal surging popularity for its Zepbound weight-loss drug
"Demand continues to outstrip even increased supply," Eli Lilly's CFO said of its Zepbound weight l…
Matthew Fox
2 mins read
Eli Lilly stock will surge 29% over the next year with its weight-loss drug on pace to do $60 billion in sales by 2030, BofA says
"We'd argue our forecasts are still conservative, as by 2030, we assume <7% of US adults will be…
Matthew Fox
3 mins read
Eli Lilly stock could soar 140% by 2028 as more people use weight-loss drugs, Goldman says
"GLP-1 based medicines will have a profound effect on the health of individuals, the manufacturers …
Matthew Fox
1 min read
Eli Lilly will be the first trillion-dollar drug company in history, billionaire investor Ken Langone says
Eli Lilly belongs to the small band of pharma stocks that have seen a stellar year, and Langone thi…
Aruni Soni
3 mins read
Eli Lilly rides the weight-loss-drug wave to a new record high, and is now worth more than $700 billion
"We haven't scratched the surface in terms of how big the [GLP-1 weight loss] drugs are going to ge…
Matthew Fox
2 mins read
The top 10 holdings of the Mormon church's $55 billion stock portfolio include a new AI stock
A mega-cap AI stock entered the top 10 holdings of the Church of Jesus Christ of Latter-day Saints'…
Matthew Fox
2 mins read
A new class of weight loss drugs is powering massive stock-market gains for Novo Nordisk and Eli Lilly
Eli Lilly now sports a market valuation of about $500 billion, making it the ninth largest US compa…
Matthew Fox
2 mins read
FDA just approved Eli Lilly's new weight-loss drug that's cheaper than Wegovy and stronger, too
Eli Lilly's tirzepatide weight-loss drug just got FDA approval. It is cheaper and possibly more eff…
Hilary Brueck
2 mins read
Stock market today: S&P 500 has its best day since 2022 as stocks rally after encouraging labor market data
Indexes climbed on Thursday as investors gained more confidence in the economy after new data showe…
Kelly Cloonan
2 mins read
Stock market today: Indexes jump as traders try to rebound from Monday's losses
"The economy will chug along and we probably won't see a recession," Goldman Sachs CEO David Solomo…
Matthew Fox
1 min read
Eli Lilly jumps 10% after it says it will seek approval for its Alzheimer's drug following designation as a breakthrough therapy by the FDA
Goldman Sachs said Eli Lilly's decision to seek accelerated approval for donanemab was ahead of its…
Matthew Fox
1 min read
Eli Lilly falls 9% after its Alzheimer's drug data underwhelms Wall Street
A successful Alzheimer's drug has been viewed as the holy grail in biotech, as it would combat a de…
Matthew Fox
2 mins read
Eli Lilly rockets 14% after experimental Alzheimer's drug slows rate of decline in trial
The drug slowed the decline in patients' ability to think by 32% compared to a placebo, according t…
Ben Winck
2 mins read
Stock splits can be rocket fuel for a company's shares. Here's who could be next.
Companies that effect forward stock splits see average returns one year later of 25% vs about 12% f…
Matthew Fox
2 mins read
Prevail Therapeutics surges 86% on news of a $1 billion buyout by Eli Lilly
Eli Lilly will pay $22.50 per share for Prevail, as well as an additional $4 per share that hinges …